Loading clinical trials...
Loading clinical trials...
The proposed research will translate research on delay discounting to the prevention of Type 2 diabetes (T2D) in persons with prediabetes. In this study, the investigators will verify target engagemen...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Leonard Epstein
Collaborators
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT07478263 · Prediabetes, Obesity (Body Mass Index >30 kg/m2)
NCT05119179 · PreDiabetes
NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more
NCT06252038 · PreDiabetes
University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine
Buffalo, New York
Fralin Biomedical Research Institute, Virginia Tech Carilion
Roanoke, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions